| ［1］ |
Everts P，Onishi K，Jayaram P，et al.Platelet-rich plasma： new performance understandings and therapeutic considerations in 2020［J］.Int J Mol Sci，2020，21（20）：7794.
|
| ［2］ |
Park YB， Kim JH， Ha CW， et al.Clinical efficacy of plateletrich plasma injection and its association with growth factors in the treatment of mild to moderate knee osteoarthritis： a randomized double-blind controlled clinical trial as compared with hyaluronic acid［J］.Am J Sports Med，2021，49（2）：487-496.
|
| ［3］ |
Bennell KL，Paterson KL，Metcalf BR，et al.Effect of intraarticular platelet-rich plasma vs placebo injection on pain and medial tibial cartilage volume in patients with knee osteoarthritis：the restore randomized clinical trial［J］.JAMA，2021，326（20）：2021-2030.
|
| ［4］ |
Wu Z， Yin J， Yue Y， et al.Application effect of different concentrations of platelet-rich plasma combined with quadriceps training on cartilage repair of knee osteoarthritis［J］.J Healthc Eng，2022，2022：7878064.
|
| ［5］ |
Jayaram P， Mitchell PJT， Shybut TB， et al.Leukocyte-rich platelet-rich plasma is predominantly anti-inflammatory compared with leukocyte-poor platelet-rich plasma in patients with mildmoderate knee osteoarthritis：a prospective，descriptive laboratory study［J］.Am J Sports Med，2023，51（8）：2133-2140.
|
| ［6］ |
Birney E.Mendelian randomization［J］.Cold Spring Harb Perspect Med，2022，12（4）：a041302.
|
| ［7］ |
Smith GD，Ebrahim S.'Mendelian randomization'： can genetic epidemiology contribute to understanding environmental determinants of disease？ ［J］.Int J Epidemiol，2003，32（1）：1-22.
|
| ［8］ |
Boef AG，Dekkers OM，le Cessie S.Mendelian randomization studies： a review of the approaches used and the quality of reporting［J］.Int J Epidemiol，2015，44（2）：496-511.
|
| ［9］ |
Gagliano Taliun SA， Evans DM.Ten simple rules for conducting aMendelian randomization study［J］.PLoS Comput Biol，2021，17（8）：e1009238.
|
| ［10］ |
Sekula P，Del Greco MF，Pattaro C，et al.Mendelian randomization as an approach to assess causality using observational data［J］.J Am Soc Nephrol，2016，27（11）：3253-3265.
|
| ［11］ |
Tachmazidou I，Hatzikotoulas K，Southam L，et al.Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data［J］.Nat Genet，2019，51（2）：230-236.
|
| ［12］ |
Zhao JH， Stacey D， Eriksson N， et al.Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets［J］.Nat Immunol，2023，24（9）：1540-1551.
|
| ［13］ |
Chen Y，Lu T，Pettersson-Kymmer U， et al.Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases［J］.Nat Genet，2023，55（1）：44-53.
|
| ［14］ |
Skrivankova VW，Richmond RC，Woolf BAR，et al.Strengthening the reporting of observational studies in epidemiology using-Mendelian randomization： the STROBE-MR statement［J］.JAMA，2021，326（16）：1614-1621.
|
| ［15］ |
Gagnon E， Mitchell PL， Manikpurage HD， et al.Impact of the gut microbiota and associated metabolites on cardiometabolic traits， chronic diseases and human longevity： a Mendelian randomization study［J］.J Transl Med，2023，21（1）：60.
|
| ［16］ |
Pritchard JK， Przeworski M.Linkage disequilibrium in humans：models and data［J］.Am J Hum Genet，2001，69（1）：1-14.
|
| ［17］ |
Burgess S，Butterworth A，Thompson SG.Mendelian randomization analysis with multiple genetic variants using summarized data［J］.Genet Epidemiol，2013，37（7）：658-665.
|
| ［18］ |
Bowden J，Del Greco MF，Minelli C，et al.Assessing the suitability of summary data for two-sampleMendelian randomi-zation analyses using MR-Egger regression：the role of the I2 statistic［J］.Int J Epidemiol，2016，45（6）：1961-1974.
|
| ［19］ |
Bowden J， Davey Smith G， Burgess S.Mendelian randomization with invalid instruments： effect estimation and bias detection through Egger regression［J］.Int J Epidemiol，2015，44（2）：512-525.
|
| ［20］ |
Burgess S，Thompson SG.Interpreting findings from Mendelian randomization using the MR-Egger method［J］.Eur J Epidemiol，2017，32（5）：377-389.
|
| ［21］ |
Greco M FD，Minelli C，Sheehan NA，et al.Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome［J］.Stat Med，2015，34（21）：2926-2940.
|
| ［22］ |
Burgess S，Small DS，Thompson SG.A review of instrumental variable estimators for Mendelian randomization［J］.Stat Methods Med Res，2017，26（5）：2333-2355.
|
| ［23］ |
Hemani G，Bowden J， Davey Smith G.Evaluating the potential role of pleiotropy in Mendelian randomization studies［J］.Hum Mol Genet，2018，27（R2）：R195-R208.
|
| ［24］ |
Chong J，Wishart DS，Xia J.Using metabo analyst 4.0 for comprehensive and integrative metabolomics data［J］.Curr Protoc Bioinformatics，2019，68（1）：e86.
|
| ［25］ |
Sobel Michael E.Asymptotic confidence intervals for indirect effects in structural equation models［J］.Sociological Methodology，1982，13：290-312.
|
| ［26］ |
Storey JD， Tibshirani R.Statistical significance for genomewide studies［J］.Proc Natl Acad Sci U S A，2003，100（16）：9440-9445.
|
| ［27］ |
Thien CB，Blystad FD，Zhan Y，et al.Loss of c-Cbl RING finger function results in high-intensity TCR signaling and thymic deletion［J］.EMBO J，2005，24（21）：3807-3819.
|
| ［28］ |
Blaize G，Daniels-Treffandier H，Aloulou M，et al.CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens［J］.Proc Natl Acad Sci U S A，2020，117（23）：12969-12979.
|
| ［29］ |
Kriegova E， Manukyan G， Mikulkova Z， et al.Gender-related differences observed among immune cells in synovial fluid in knee osteoarthritis［J］.Osteoarthritis Cartilage，2018，26（9）：1247-1256.
|
| ［30］ |
Sohn HS，Choi JW，Jhun J，et al.Tolerogenic nanoparticles induce type Ⅱ collagen-specific regulatory T cells and ameliorate osteoarthritis［J］.Sci Adv，2022，8（47）：eabo5284.
|
| ［31］ |
Carrion EA，Moses MM，Behringer RR.FGF5［J］.Differentiation，2024，139：100736.
|
| ［32］ |
Mohammadi M， Olsen SK， Ibrahimi OA.Structural basis for fibroblast growth factor receptor activation［J］.Cytokine Growth Factor Rev，2005，16（2）：107-137.
|
| ［33］ |
Pethö-Schramm A， Müller HJ， Paus R.FGF5 and the murine hair cycle［J］.Arch Dermatol Res， 1996，288（5-6）：264-246.
|
| ［34］ |
Chen M，Lu Y，Liu Y， et al.Injectable microgels with hybrid exosomes of chondrocyte-targeted fgf18 gene-editing and selfrenewable lubrication for osteoarthritis therapy［J］.Adv Mater，2024，36（16）：e2312559.
|
| ［35］ |
Welhaven HD， Welfley AH， Brahmachary P， et al.Metabolomic profiles and pathways in osteoarthritic human cartilage： a comparative analysis with healthy cartilage［J］.Metabolites，2024，14（4）：183.
|
| ［36］ |
Li JT，Zeng N，Yan ZP，et al.A review of applications of metabolomics in osteoarthritis［J］.Clin Rheumatol，2021，40（7）：2569-2579.
|
| ［37］ |
Zhu S，Makosa D，Miller B，et al.Glutathione as a mediator of cartilage oxidative stress resistance and resilience during aging and osteoarthritis［J］.Connect Tissue Res，2020，61（1）：34-47.
|
| ［38］ |
Kumar P，Liu C，Suliburk J， et al.Supplementingglycine and Nacetylcysteine （GlyNAC） in older adults improves glutathione deficiency，oxidative stress，mitochondrial dysfunction，inflammation，physical function，and aging hallmarks： a randomized clinical trial［J］.J Gerontol A Biol Sci Med Sci，2023，78（1）：75-89.
|
| ［39］ |
Golovach I，Rekalov D，Akimov OY，et al.Molecular mechanisms and potential applications of chondroitin sulphate in managing post-traumatic osteoarthritis［J］.Reumatologia， 2023，61（5）：395-407.
|
| ［40］ |
Ootake T，Ishii T，Sueishi K，et al.Effects of mechanical stress and deficiency of dihydrotestosterone or 17β-estradiol on temporomandibular joint osteoarthritis in mice［J］.Osteoarthritis Cartilage，2021，29（11）：1575-1589.
|
| ［41］ |
Tetlow LC，Woolley DE.Histamine， histamine receptors （H1 and H2）， and histidine decarboxylase expression by chondrocytes of osteoarthritic cartilage：an immunohistochemical study［J］.Rheumatol Int，2005，26（2）：173-178.
|